Please use this identifier to cite or link to this item:
Title: [¹⁸F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment.
Austin Authors: Jeong, Hye Jin;Lee, Hyon;Lee, Sang Yoon;Seo, Seongho;Park, Kee Hyung;Lee, Yeong Bae;Shin, Dong Jin;Kang, Jae Myeong;Yeon, Byeong Kil;Kang, Seung Gul;Cho, Jaelim;Seong, Joon Kyung;Okamura, Nobuyuki;Villemagne, Victor L ;Na, Duk L;Noh, Young
Affiliation: Department of Health Science and Technology, GAIHST, Gachon University, Incheon, Korea
Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia
Department of Neurology, Gachon University Gil Medical Center, Incheon, Korea
Centre for PET, Austin Health, Heidelberg, Victoria, Australia
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Department of Biomedical Engineering, Korea University, Seoul, Korea
Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia
Department of Neuroscience, College of Medicine, Gachon University, Incheon, Korea
Neuroscience Research Institute, Gachon University, Incheon, Korea
Department of Occupational and Environmental Medicine, Gachon University Gil Medical Center, Incheon, Korea
Department of Psychiatry, Gachon University Gil Medical Center, Incheon, Korea
Department of Artificial Intelligence, Korea University, Seoul, Korea
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, Korea
Tohoku Medical and Pharmaceutical University, Sendai, Japan
Issue Date: Apr-2020
Publication information: Journal of clinical neurology (Seoul, Korea) 2020; 16(2): 202-214
Abstract: Mild cognitive impairment (MCI) is a condition with diverse clinical outcomes and subgroups. Here we investigated the topographic distribution of tau in vivo using the positron emission tomography (PET) tracer [¹⁸F]THK5351 in MCI subgroups. This study included 96 participants comprising 38 with amnestic MCI (aMCI), 21 with nonamnestic MCI (naMCI), and 37 with normal cognition (NC) who underwent 3.0-T MRI, [¹⁸F]THK5351 PET, and detailed neuropsychological tests. [¹⁸F]flutemetamol PET was also performed in 62 participants. The aMCI patients were further divided into three groups: 1) verbal-aMCI, only verbal memory impairment; 2) visual-aMCI, only visual memory impairment; and 3) both-aMCI, both visual and verbal memory impairment. Voxel-wise statistical analysis and region-of-interest -based analyses were performed to evaluate the retention of [¹⁸F]THK5351 in the MCI subgroups. Subgroup analysis of amyloid-positive and -negative MCI patients was also performed. Correlations between [¹⁸F]THK5351 retention and different neuropsychological tests were evaluated using statistical parametric mapping analyses. [¹⁸F]THK5351 retention in the lateral temporal, mesial temporal, parietal, frontal, posterior cingulate cortices and precuneus was significantly greater in aMCI patients than in NC subjects, whereas it did not differ significantly between naMCI and NC participants. [¹⁸F] THK5351 retention was greater in the both-aMCI group than in the verbal-aMCI and visualaMCI groups, and greater in amyloid-positive than amyloid-negative MCI patients. The cognitive function scores were significantly correlated with cortical [¹⁸F]THK5351 retention. [¹⁸F]THK5351 PET might be useful for identifying distinct topographic patterns of [¹⁸F]THK5351 retention in subgroups of MCI patients who are at greater risk of the progression to Alzheimer's dementia.
DOI: 10.3988/jcn.2020.16.2.202
ORCID: 0000-0003-3765-8546
Journal: Journal of clinical neurology (Seoul, Korea)
PubMed URL: 32319236
ISSN: 1738-6586
Type: Journal Article
Subjects: mild cognitive impairment
neurofibrillary tangles
positron emission tomography
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Feb 2, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.